• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 新型冠状病毒:我们所处的位置和我们所了解的情况。

2019 Novel coronavirus: where we are and what we know.

机构信息

Institute of Allergy and Immunology, School of Medicine, Shenzhen University, Shenzhen, China.

Institute of Medical Physics, University of Sydney, Sydney, Australia.

出版信息

Infection. 2020 Apr;48(2):155-163. doi: 10.1007/s15010-020-01401-y. Epub 2020 Feb 18.

DOI:10.1007/s15010-020-01401-y
PMID:32072569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7095345/
Abstract

There is a current worldwide outbreak of a new type of coronavirus (2019-nCoV), which originated from Wuhan in China and has now spread to 17 other countries. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak sites and from laboratories supporting the investigation. This paper aggregates and consolidates the virology, epidemiology, clinical management strategies from both English and Chinese literature, official news channels, and other official government documents. In addition, by fitting the number of infections with a single-term exponential model, we report that the infection is spreading at an exponential rate, with a doubling period of 1.8 days.

摘要

目前,一种新型冠状病毒(2019-nCoV)正在全球范围内爆发,该病毒源自中国武汉,现已传播到 17 个其他国家。各国政府面临着越来越大的压力,需要阻止疫情蔓延成为全球卫生紧急事件。在现阶段,准备工作、透明度和信息共享对于风险评估和开展疫情控制活动至关重要。这些信息应包括来自疫情发生地和支持调查的实验室的报告。本文汇总和整合了来自英文和中文文献、官方新闻渠道和其他官方政府文件的病毒学、流行病学和临床管理策略。此外,通过将感染人数拟合为单期指数模型,我们报告感染正在以指数级速度传播,倍增期为 1.8 天。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf4/7095345/20007a7b7c03/15010_2020_1401_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf4/7095345/20007a7b7c03/15010_2020_1401_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf4/7095345/20007a7b7c03/15010_2020_1401_Fig1_HTML.jpg

相似文献

1
2019 Novel coronavirus: where we are and what we know.2019 新型冠状病毒:我们所处的位置和我们所了解的情况。
Infection. 2020 Apr;48(2):155-163. doi: 10.1007/s15010-020-01401-y. Epub 2020 Feb 18.
2
The SARS-CoV-2 outbreak: What we know.新型冠状病毒爆发:我们所知道的。
Int J Infect Dis. 2020 May;94:44-48. doi: 10.1016/j.ijid.2020.03.004. Epub 2020 Mar 12.
3
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
4
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019(COVID-19)大流行期间癌症患者管理的实用方法:国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
5
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.新型冠状病毒(SARS-CoV-2)爆发的前 75 天:最新进展、预防和治疗。
Int J Environ Res Public Health. 2020 Mar 30;17(7):2323. doi: 10.3390/ijerph17072323.
6
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
7
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.基于现有证据对 2019 年新型冠状病毒(SARS-CoV-2)的回顾。
Int J Antimicrob Agents. 2020 Jun;55(6):105948. doi: 10.1016/j.ijantimicag.2020.105948. Epub 2020 Mar 19.
8
Emergence of novel coronavirus SARS-CoV2 in China and the response in Mexico.新型冠状病毒SARS-CoV2在中国的出现及墨西哥的应对措施。
Gac Med Mex. 2020;156(2):91-93. doi: 10.24875/GMM.M20000345.
9
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病(COVID-19)疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
10
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和新型冠状病毒(COVID-19)疫情,最新和最大的全球健康威胁:我们从中吸取了哪些教训?
Int J Epidemiol. 2020 Jun 1;49(3):717-726. doi: 10.1093/ije/dyaa033.

引用本文的文献

1
Health-Related Quality of Life and Functional Status of Post-COVID-19 Patients.新冠病毒感染康复者的健康相关生活质量和功能状态
Int J Environ Res Public Health. 2025 Feb 25;22(3):338. doi: 10.3390/ijerph22030338.
2
Bilateral Brachial Neuritis after COVID-19: Case Report.新型冠状病毒肺炎后双侧臂丛神经炎:病例报告
Rev Bras Ortop (Sao Paulo). 2024 Dec 27;59(Suppl 2):e173-e175. doi: 10.1055/s-0042-1750756. eCollection 2024 Nov.
3
Exploring Prehospital Data for Pandemic Preparedness: A Western Brazilian Amazon Case Study on COVID-19.

本文引用的文献

1
Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates.新型冠状病毒 2019-nCoV (COVID-19):流行病学参数和疫情规模的早期估计。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200265. doi: 10.1098/rstb.2020.0265. Epub 2021 May 31.
2
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
3
Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions.
探讨大流行准备的院前数据:巴西西部亚马逊地区 COVID-19 的案例研究。
Int J Environ Res Public Health. 2024 Sep 18;21(9):1229. doi: 10.3390/ijerph21091229.
4
Intimate partner violence and associated factors among women during the COVID-19 pandemic in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚新冠疫情期间女性亲密伴侣暴力行为及其相关因素:一项系统综述与荟萃分析
Front Glob Womens Health. 2024 Aug 23;5:1425176. doi: 10.3389/fgwh.2024.1425176. eCollection 2024.
5
COVID-19 burden in Iran: disability-adjusted life years analysis from hospital data, 2020-2021.伊朗的新冠疫情负担:基于2020 - 2021年医院数据的伤残调整生命年分析
Arch Public Health. 2024 Aug 26;82(1):135. doi: 10.1186/s13690-024-01355-9.
6
Lessons from the COVID-19 pandemic: the unequal burden of COVID-19 on vulnerable populations in the Brazilian Central-West.从 COVID-19 大流行中吸取的教训:巴西中西部脆弱人群 COVID-19 的不平等负担。
Cad Saude Publica. 2024 Aug 19;40(8):e00199623. doi: 10.1590/0102-311XEN199623. eCollection 2024.
7
A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management.冠状病毒感染的叙述性概述:临床体征和症状、病毒进入和复制、治疗方式和管理。
Curr Top Med Chem. 2024;24(21):1883-1916. doi: 10.2174/0115680266296095240529114058.
8
Characteristics and Outcomes of Coronavirus Disease- 2019 Among Pregnant Women in Saudi Arabia; a Retrospective Study.沙特阿拉伯孕妇中2019冠状病毒病的特征与结局;一项回顾性研究
Int J Womens Health. 2024 Mar 14;16:475-490. doi: 10.2147/IJWH.S445950. eCollection 2024.
9
Evaluation of Global Post-Outbreak COVID-19 Treatment Interventions: A Systematic Review and Bibliometric Analysis of Randomized Controlled Trials.全球新冠疫情爆发后治疗干预措施的评估:随机对照试验的系统评价与文献计量分析
J Multidiscip Healthc. 2023 Dec 23;16:4193-4209. doi: 10.2147/JMDH.S448786. eCollection 2023.
10
Outcomes and risk factors of SARS-CoV-2 omicron variant in B-cell lymphoma patients following CD19 targeted CAR-T therapy.COVID-19 奥密克戎变异株在接受 CD19 靶向嵌合抗原受体 T 细胞(CAR-T)治疗的 B 细胞淋巴瘤患者中的结局和风险因素。
Cancer Med. 2023 Nov;12(22):20838-20846. doi: 10.1002/cam4.6657. Epub 2023 Nov 14.
2019新型冠状病毒传播风险评估及其对公共卫生干预措施的启示
J Clin Med. 2020 Feb 7;9(2):462. doi: 10.3390/jcm9020462.
4
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
5
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情,该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
6
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.新型冠状病毒在武汉持续爆发中的进化及其刺突蛋白对人类传播风险的建模。
Sci China Life Sci. 2020 Mar;63(3):457-460. doi: 10.1007/s11427-020-1637-5. Epub 2020 Jan 21.
7
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
8
The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020.2020年中国武汉新型冠状病毒的传播范围
J Clin Med. 2020 Jan 24;9(2):330. doi: 10.3390/jcm9020330.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例,提示存在人际传播:一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.